Fulgent Genetics, Inc. (FLGT)
Services-Medical Laboratories
Latest Price
$16.55
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
34.00
P/B Ratio
0.49
Valuation metrics
adjust assumptions →Base FCF: $235M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$130.41
+688% upside
Institutional Ownership
52.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.77M | $44.0M | 9.62% | -187.7K | 2026-03-31 |
| RTW INVESTMENTS, LP | 1.29M | $20.0M | 4.47% | +584.0K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 880.1K | $13.0M | 3.05% | -- | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 671.7K | $10.0M | 2.33% | -217.3K | 2026-03-31 |
| Invenomic Capital Management LP | 610.3K | $9.0M | 2.12% | +579.2K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 584.2K | $9.0M | 2.02% | +76.0K | 2026-03-31 |
| AMERIPRISE FINANCIAL INC | 563.4K | $8.0M | 1.95% | +63.9K | 2026-03-31 |
| STATE STREET CORP | 529.4K | $8.0M | 1.83% | +35.7K | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 486.8K | $7.0M | 1.69% | -214.5K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 401.8K | $6.0M | 1.39% | -537.6K | 2026-03-31 |